Efficacy of a multitargeted, salicylic acid‐based dermocosmetic cream compared to benzoyl peroxide 5% in Acne vulgaris: Results from a randomized study

Abstract

AbstractIntroductionAcne vulgaris (acne) is characterized by both inflammatory and non‐inflammatory lesions. Benzoyl peroxide (BPO) 5% is approved to treat acne but may cause skin irritation and/or contact allergy.ObjectivesTo compare the benefit in acne of a multitargeted dermocosmetic cream containing salicylic acid, lipohydroxy acid, niacinamide, 2‐oleamido‐1,3‐octadecanediol, piroctone olamine, zinc, Aqua posae filiformis, and thermal spring water (DC‐Eff) to BPO 5% gel.Materials and Methods150 Caucasian subjects (50% female) aged between 18 and 40 years, with mild to moderate acne according to the GEA (Global Evaluation of Acne) grading system were randomized into two parallel groups (DC‐Eff or BPO to be applied twice daily for 56 days). IGA (investigator global assessment), GEA, lesion count, clinical signs and symptoms, and subject assessment were evaluated at baseline, and after 28 and 56 days (D28 and D56) of treatment.ResultsThe responder analyses of the IGA and GEA scores showed that 62.2% and 47.3%, respectively, in the DC‐Eff, compared with 50.0% and 36.5%, respectively, in the BPO, had improved by at least one point at D56. Inflammatory, non‐inflammatory, and total lesion counts significantly (p < 0.0001) decreased with both products from baseline, with no between‐group difference. Subjects considered that their skin was smoother and that DC‐Eff was easy to apply. DC‐Eff was better tolerated than BPO.ConclusionsDC‐Eff applied twice daily is as beneficial as BPO in improving mild‐to‐moderate acne. DC‐Eff was better tolerated than BPO and highly appreciated.